Introduction {#mjx015s1}
============

Synapses are asymmetric intercellular junctions communicating with different neurons. These junctions are basal units required to establish neuronal networks for normal nervous system function. They are composed of presynaptic and postsynaptic areas that are consisted of many adhesion molecules ([@mjx015C9]). Among synaptic adhesion molecules, neuroligins (Nlgs) are postsynaptic single transmembrane proteins with an extracellular domain that exhibits homology to acetylcholinesterase (AChE) ([@mjx015C13]). Nlgs and their binding partners neurexins (Nrxs) form heterophilic adhesive complexes via an extracellular α/β hydrolase fold domain ([@mjx015C27]). Nlgs can organize presynaptic and postsynaptic structures and are essential for synapse development and synaptic transmission ([@mjx015C17]). The intracellular region of Nlgs can interact with several postsynaptic molecules, which are thought to recruit postsynaptic proteins to synaptic sites, such as PSD-95 ([@mjx015C14]).

Mutations in human NLGs have been found to be associated with autism and other neurodevelopmental impairments, e.g. the R451C mutation in NLG3 and the R87W mutation in NLG4 ([@mjx015C15]; [@mjx015C32]; [@mjx015C16]). These mutations give rise to defects in protein folding and trafficking ([@mjx015C7]). R451C mutation in NLG3 leads to activation of the unfolded protein response ([@mjx015C33]) and also differentially alters hippocampal and cortical synaptic function ([@mjx015C8]). However, the precise mechanisms by which these mutations give rise to defects in Nlg functions remain unclear. It is likely that aberrant protein maturation process and mislocalization of mutant NLGs contribute to their potential pathogenesis. Whether the autism-associated mutation affects the proteolytic cleavages of Nlgs are still mysteries.

One crucial biological process regulating protein maturation, trafficking, and activity is proteolytic cleavage. It is universally involved in various biological events such as cell signaling, development, and apoptosis ([@mjx015C35]). Unlike protein precursors usually cleaved in the endoplasmic reticulum (ER) or Golgi, Nlgs display strong tendency of local proteolytic process based on current findings. Rodent Nlg1 undergoes activity-dependent proteolytic cleavage by ADAM10/MMP9 on synapses, which may negatively regulate synapse remodeling ([@mjx015C23]; [@mjx015C31]). While the N-terminal ectodomain is secreted to the outside of the cell membrane, Nlg1 C-terminal fragment (CTF) is subsequently cleaved by presenilin/γ-secretase ([@mjx015C31]). These further cleaved CTFs regulate spine dynamics and synaptic plasticity via LIMK1/cofilin-mediated actin reorganization ([@mjx015C21]). The secreted N-terminal fragments (NTFs) of Nlg3 promote robust glioma cell proliferation via PI3K−mTOR pathway ([@mjx015C34]), suggesting that Nlg3 proteins also undergo proteolytic cleavage. The AChE, a homology to Nlg extracellular domain, also undergoes proteolytic cleavage playing important roles in apoptosis ([@mjx015C36]). Collectively, post-translational proteolytic cleavages are common modifications in protein maturation and function. Therefore, whether the proteolytic cleavage modification is involved in Nlg maturation and trafficking is urgent to be determined.

Intriguingly, Nlgs with less molecular weight can be detected in *Drosophila* as well. Among four Nlg homologs in *Drosophila*,  *Drosophila* neuroligin 2 (DNlg2) and DNlg3 have both full-length and partial-length forms ([@mjx015C1]; [@mjx015C30]; [@mjx015C22]; [@mjx015C12]; [@mjx015C19]; [@mjx015C37]; [@mjx015C24]). However, the mechanisms of their protein processing events and the function of partial-length proteins have yet to be determined. It is very important to verify whether the cleavage mechanisms and functions of other Nlgs are similar or specific.

In this study, we demonstrate that, different from rodent Nlgs, DNlg2 is cleaved in the ER rather than in the synapse cleft. This protein processing event is necessary for its maturation and trafficking. Cleavage of DNlg2 is ubiquitous in *Drosophila* and occurs throughout development. The full-length DNlg2 proteins are immature and retained in the ER through the association with the ER chaperon protein BiP. Mature CTF but not full-length DNlg2 proteins locate at synapse and promote synapse development. Interestingly, we also found that autism-associated R598C mutation leads to severe defects in DNlg2 cleavage and trafficking. Together, our results indicate a significant advancement in understanding the diverse mechanisms and functions of Nlg proteolytic cleavage and suggest a potential autism pathogenesis.

Results {#mjx015s2}
=======

DNlg2 is ubiquitously cleaved {#mjx015s2a}
-----------------------------

Previous study reported that only 4.8-kb *dnlg2* mRNA was detected in wild-type (WT) flies, which was predicted to give rise to 130 kDa full-length proteins ([@mjx015C30]). However, in our immunoblotting analysis, the predominant band observed was 70 kDa ([@mjx015C30]). Immunoprecipitation experiment showed that endogenous 130 kDa DNlg2 proteins really existed in WT flies at very low level compared with the 70 kDa DNlg2 ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). In addition, three *neurexin* genes have been identified in mammalian, each encoding a longer α-Nrx and a shorter β-Nrx by independent promoters ([@mjx015C27]). Therefore, we first investigated whether the 70 kDa DNlg2 is cleaved from the full-length DNlg2 or encoded from another promoter.

Site-directed *UAS-dnlg2* transgene was generated using the *φ31*-mediated integration system ([@mjx015C2]). We took the advantage of the *Gal4*/*Tub-Gal80*^*ts*^ system, which allows temperature inducible activation of gene expression. At the permissive temperature (25°C), binding of *Gal80*^*ts*^ to *Gal4* prevents the transcription of DNlg2 ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). After shifting to 30°C, *Gal80*^*ts*^ was inactivated, allowing *Gal4* to activate the transcription of *dnlg2*, which was then translated into DNlg2 protein ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}). Immunoblotting results showed that the 130 kDa DNlg2 was detected earlier than the 70 kDa DNlg2 (Figure [1](#mjx015F1){ref-type="fig"}A). And the signal of 130 kDa DNlg2 was also stronger than that of the 70 kDa DNlg2 after 24−37 h incubation at 30°C (Figure [1](#mjx015F1){ref-type="fig"}A). After incubation at 25°C for 9 h, a dramatic reduction in the expression of the 130 kDa DNlg2 and a concomitant increase in the level of the 70 kDa DNlg2 were observed (Figure [1](#mjx015F1){ref-type="fig"}A). These results indicate that the 70 kDa DNlg2 is cleaved from the 130 kDa DNlg2. The fact that the 70 kDa DNlg2 was detected nearly 16 h later than the 130 kDa DNlg2 indicates that the cleavage of DNlg2 could be a slow process (Figure [1](#mjx015F1){ref-type="fig"}A).

![Proteolytic cleavage of DNlg2. (**A**) Immunoblotting analysis of *Gal4/Tub-Gal80*^*ts*^-controlled DNlg2-overexpressing muscle cells. Entrainment temperature and incubated time (h) are shown at the top. (**B**) Immunoblotting analysis of WT *Drosophila* samples at different developmental stages (1−4: embryonic 0−6 h, 6−12 h, 12−18 h, 18−24 h; 5−8: larval of 1st, 2nd, early 3rd, late 3rd instar; 9−11: pupal head after 24, 48, 72 h pupation; 12−14: adult head 1 day, 3 days, 5 days). (**C**) Immunoblotting analysis of *dnlg2* mutant, WT, *elav-Gal4* \> *UAS-dnlg2*, *da-Gal4* \> *UAS-dnlg2*, *gmr*-*Gal4* \> *UAS-dnlg2*, and *repo*-*Gal4* \> *UAS-dnlg2* fly heads. (**D**) Immunoblotting analysis of S2 cells transfected with *pAc5.1-dnlg2* plasmid after 24, 36, 48, or 72 h. (**E**) Immunoblotting analysis of protease inhibitor (PI)-treated samples. DNlg2 proteins were overexpressed with the *Gal4/Tub-Gal80*^*ts*^ expression system for 37 h. Then dissected muscle cells were incubated at 25°C with or without PI cocktail for 6 or 12 h. (**F**) Immunoblotting analysis of human 293T cells transfected with 0, 0.5, 1, or 2 μg *pcDNA3.1-dnlg2* plasmid. The rabbit anti-DNlg2^CTF^ antibodies were used.](mjx015f01){#mjx015F1}

We next asked whether the 70 kDa DNlg2 is expressed in all developmental stages of WT flies. Interestingly, immunoblotting results showed that from embryonic stage to adult stage, only the 70 kDa DNlg2 can be constantly detected (Figure [1](#mjx015F1){ref-type="fig"}B). These results suggest that the 70 kDa DNlg2 is the predominant form existing in all *Drosophila* developmental stages.

We also investigated the tissue specificities of the 70 kDa DNlg2. Using the *UAS/Gal4* system, *dnlg2* cDNA was expressed specifically in neurons with *elav*-*Gal4*, in all cells with *da*-*Gal4*, in eyes with *gmr*-*Gal4*, or in glial cells with *repo*-*Gal4*. We performed immunoblotting analysis and found that DNlg2 was expressed and cleaved in all these tissues with similar ratios (Figure [1](#mjx015F1){ref-type="fig"}C). DNlg2 was overexpressed in S2 cells by transient transfection with a *pAc5.1/V5-His-A-dnlg2* plasmid. We found that the 70 kDa DNlg2 also existed in DNlg2-overexpressing S2 cells (Figure [1](#mjx015F1){ref-type="fig"}D). These observations indicate that the 70 kDa DNlg2 generally exists in various kinds of cells when DNlg2 is overexpressed.

DNlg2 cleavage is not an automatic reaction {#mjx015s2b}
-------------------------------------------

To further investigate whether the cleavage of DNlg2 is a specific event mediated by protease in *Drosophila* or just an automatic cleavage event, we tested the influence of protease inhibitor (PI) cocktail on DNlg2 cleavage. DNlg2 was expressed with the *Gal4*/*Tub-Gal80*^*ts*^ system. After 37 h at 30°C, third instar larval muscle cells were dissected and treated with or without PI for 6 or 12 h in cell culture medium. Immunoblotting results showed that without PI, the level of the 70 kDa DNlg2 was increased, while the level of the 130 kDa DNlg2 was decreased after 6 or 12 h (Figure [1](#mjx015F1){ref-type="fig"}E). However, when treated with PI, both 70 kDa and 130 kDa protein levels did not markedly change compared with control (Figure [1](#mjx015F1){ref-type="fig"}E). This means that PI suppresses DNlg2 cleavage efficiently. Only the 130 kDa DNlg2 could be detected when DNlg2 was overexpressed in human 293T, human SH-SY5Y, or mouse Neuro-2A cells by transient transfection with *pcDNA3.1*-*dnlg2* plasmids (Figure [1](#mjx015F1){ref-type="fig"}F and [Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}), indicating that DNlg2 is not cleaved in non-*Drosophila* cells.

Meanwhile, we examined whether DNlg2 can be self-cleaved *in vitro*. DNlg2 was expressed with the *Gal4/Tub-Gal80*^*ts*^ system and was immunoprecipitated from third instar larval muscle cells after 37 h. The purified DNlg2 was treated with the buffer suitable for *in vitro* self-cleavage ([@mjx015C20]). At various time points, samples were withdrawn and analyzed by immunoblotting. We found that ratios of the 70 kDa DNlg2 to the 130 kDa DNlg2 were similar during 0−48 h of incubation ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}). Taken together, these observations demonstrated that the cleavage of DNlg2 is not an autoproteolytic process but rather a specific *Drosophila* protease(s)-dependent event.

Proteolytic cleavage of DNlg2 is achieved in the ER {#mjx015s2c}
---------------------------------------------------

To unveil the proteolytic mechanism of DNlg2, we determined the subcellular component in which the cleavage takes place. Previous experiments have shown that the cleavage of mammal Nlg1 occurs at neural cell surface ([@mjx015C31]). Thus, we first examined whether the 130 kDa DNlg2 could locate on cell surface. A plasma membrane extraction kit was used to purify the plasma membrane proteins from whole-cell lysates of WT or DNlg2-overexpressing fly heads. Immunoblotting results showed that only the 70 kDa DNlg2 could be detected in the plasma fractions (Figure [2](#mjx015F2){ref-type="fig"}A). This means that most of the 130 kDa proteins are present in cytoplasm but not on plasma membrane. In addition, two intracellular proteins Fmr1 and α-Tubulin were used as negative controls that were unable to be detected in plasma membrane fractions (Figure [2](#mjx015F2){ref-type="fig"}A). These observations indicate that the 130 kDa DNlg2 cannot locate on cell surface, and, therefore, the cleavage may be an intracellular reaction.

![Proteolytic cleavage of DNlg2 occurs in the ER. (**A**) Immunoblotting analysis of samples collected from purified plasma membrane fractions. Blots were probed with antibodies against DNlg2, Fmr1, and α-Tubulin. Lysate means whole-cell fractions. Plasma means purified plasma membrane fractions. OE means DNlg2-overexpressing cells. (**B**) Immunoblotting analysis of samples collected from a 10%--30% density gradient separation prepared from adult WT heads. Blots were probed with antibodies against DNlg2 intracellular domain, the Golgi protein Syn16, and the ER protein BiP. (**C**) DNlg2 proteins were overexpressed and immunoprecipitated, and then digested with or without 2.5 μg/ml trypsin for 1, 3, 6, or 10 min. Samples were then followed by immunoblotting with anti-DNlg2 antibody. The rabbit anti-DNlg2^CTF^ antibodies were used.](mjx015f02){#mjx015F2}

In order to identify the proposed intracellular organelles that responsible for DNlg2 cleavage, the ER and Golgi fractions were separated by using an ER isolation kit. Intracellular organelle fractions were extracted from a 10%--30% density gradient separation prepared from adult WT heads and subjected to immunoblotting with antibodies against the Golgi protein Syn16 ([@mjx015C38]), the ER protein BiP ([@mjx015C28]), and the DNlg2^CTF^, respectively. The 130 kDa DNlg2 was found to co-fractionate with BiP, while the 70 kDa DNlg2 was co-fractionated with both BiP and Syn16 (Figure [2](#mjx015F2){ref-type="fig"}B). These results strongly suggest that DNlg2 is cleaved in the ER and then delivered to Golgi as the 70 kDa isoform.

To further confirm the cleavage reaction of DNlg2 in the ER, we examined the proteolytic cleavage of KDEL-tagged DNlg2. KDEL plays important roles in the localization of many proteins in the ER ([@mjx015C29]). This signal determines retrieval from post-ER located compartments in the exocytic pathway by virtue of retrograde transport ([@mjx015C29]). We generated four types of reconstructed DNlg2 ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}) and found that types 1 and 2 could not be cleaved whereas types 3 and 4 could ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). Because the transmembrane domain was removed in types 1 and 2 but kept in types 3 and 4, we concluded that the transmembrane domain is critical in the cleavage process of DNlg2. The KDEL-tagged DNlg2 proteins could also be cleaved, confirming that the cleavage of DNlg2 is achieved in the ER ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}).

Limited trypsin digestion has been used to study protein folding ([@mjx015C10]; [@mjx015C7]), because Immature proteins are more sensitive to trypsin digestion. To determine differences between the 130 kDa DNlg2 and the 70 kDa DNlg2, we performed a trypsin digestion experiment. DNlg2 proteins were overexpressed and immunoprecipitated, followed by treatment with limited trypsin. At a trypsin concentration of 2.5 μg/ml, the extent of protein degradation was analyzed over 1, 3, 6, or 10 min (Figure [2](#mjx015F2){ref-type="fig"}C). Immunoblotting results showed that levels of the 130 kDa DNlg2 were continuously reduced from 1 min to 10 min, nearly all proteins degraded after 10 min (Figure [2](#mjx015F2){ref-type="fig"}C). In contrast, no changes were observed in the 70 kDa DNlg2 levels (Figure [2](#mjx015F2){ref-type="fig"}C). Parallel treatment without trypsin showed no protein degradation for both 130 kDa and 70 kDa DNlg2 (Figure [2](#mjx015F2){ref-type="fig"}C). This suggests that the 130 kDa DNlg2 is immature, located in the ER, and needs to be cleaved.

Y642−T698 region is required for DNlg2 cleavage {#mjx015s2d}
-----------------------------------------------

To elucidate the physiological significance of DNlg2 cleavage, we mapped the proteolytic cleavage site by mutational analysis. Based on the molecular weight of the CTF, the regions around A611 of DNlg2 were predicted to be the candidate site for cleavage (Figure [3](#mjx015F3){ref-type="fig"}A). Therefore, DNlg2 variants with 50 or 100 amino acid deletion around A611 were constructed (named Δ1, Δ2, Δ3, Δ4, or Δ5) and then transfected into S2 cells (Figure [3](#mjx015F3){ref-type="fig"}A). No obvious effects were observed in Δ1 or Δ5 mutant constructs, suggesting that these regions are not necessary for DNlg2 cleavage (Figure [3](#mjx015F3){ref-type="fig"}B). Less amount of the 70 kDa DNlg2 was detected in Δ2 variant, indicating that this region partially contributes to the efficiency of DNlg2 cleavage, but the cleavage site is still beyond this region (Figure [3](#mjx015F3){ref-type="fig"}B). Interestingly, only full-length but not the 70 kDa DNlg2 could be observed in both Δ3 and Δ4 variants (Figure [3](#mjx015F3){ref-type="fig"}B). Thus, the overlap sequences between Δ3 and Δ4 (V649−P704) seemed to be required for the cleavage of DNlg2.

![Y642−T698 region is required for DNlg2 cleavage. (**A**) Schematic diagram of DNlg2 structure. Positions of representative amino acids are shown above. Amino acid lengths and positions of deleted DNlg2 fragments are shown below (Δ1: A500−D599, Δ2: F550−V649, Δ3: A600−A699, Δ4: A650−E749, Δ5: N734−L784, Δ6: V649−G659, Δ7: L660−E674, Δ8: R675−A689, and Δ9: K690−P704). (**B**) Immunoblotting analysis of S2 cells transfected with large deleted DNlg2 fractions. (**C**) Immunoblotting analysis of S2 cells transfected with small deleted DNlg2 sequences. (**D**) Schematic depiction of protein sequences of alanine substitution mutant DNlg2. (**E**) Immunoblotting analysis of S2 cells transfected with alanine substitution mutant DNlg2 constructs. The rabbit anti-DNlg2^CTF^ antibodies were used in **B**, **C**, and **E**.](mjx015f03){#mjx015F3}

To further narrow down the essential region for cleavage, we generated another series of DNlg2 variants with 11 or 15 amino acid deletion within V649−P704 (named Δ6, Δ7, Δ8, or Δ9) (Figure [3](#mjx015F3){ref-type="fig"}A). Surprisingly, in all of these four variants, only full-length but not the cleaved 70 kDa DNlg2 could be detected (Figure [3](#mjx015F3){ref-type="fig"}C). These results further demonstrated that the overlap sequences between Δ3 and Δ4 (V649−P704) are critical for DNlg2 cleavage. These results also indicate that the cleavage of DNlg2 is determined by a large fragment rather than several amino acids.

Another way to identify the functional region is to perform an amino acid substitution assay. Because of the smaller size, no functional group, and smallest effects on the original protein, alanine is widely chosen to substitute amino acids in a protein, such as in the study of Nlg1 cleavage ([@mjx015C31]). We then constructed a series of alanine substitutions within DNlg2 and named them SA, SB, SC, SD, SE, SF, SG, SH, SI, or SJ, respectively (Figure [3](#mjx015F3){ref-type="fig"}D). Only SI and SJ were cleaved, while all other mutations inhibited DNlg2 proteolytic cleavage (Figure [3](#mjx015F3){ref-type="fig"}E). Taken together, these data suggest that the region between Y642 and T698 is critical for the proteolytic cleavage of DNlg2 and the cleavage site is located in this region.

Autism-associated R598C mutation prevents the cleavage of DNlg2 {#mjx015s2e}
---------------------------------------------------------------

*In vitro* studies showed that autism-associated R451C mutation in NLG3 resulted in defects in the localization of NLG3 at the cell membrane ([@mjx015C4]). We were, therefore, interested in determining whether this mutation leads to perturbed protein trafficking in DNlg2. By aligning the amino acid sequences of Nlgs among human, mouse, and *Drosophila*, we found that DNlg2 R598 is homologous with Nlg3 R451 (Figure [4](#mjx015F4){ref-type="fig"}A). This arginine is identical in all Nlgs, suggesting its critical and conserved roles in Nlg function (Figure [4](#mjx015F4){ref-type="fig"}A).

![R598C mutant DNlg2 shows abnormal proteolytic cleavage and trafficking. (**A**) Multiple sequence alignment of *Homo sapiens* (Hs), *Mus musculus* (Ms), and *Drosophila melanogaster* (Dm) Nlgs. Red star points at the Hs NLG3 R541 amino acid. Hs NLG1 (NP_055747.1), Hs NLG 2 (NP_065846), Hs NLG 3 (NP_061850), Hs NLG 4 (NP_065793.1), Mm Nlg1 (NP_619607.2), Mm Nlg2 (NP_942562.2), Mm Nlg3 (NP_766520.2), Mm Nlg4 (ABS19580), Dm Nlg1 (NP_731172), Dm Nlg2 (NP_523496.1), Dm Nlg3 (NP_001036685.2),  and Dm Nlg4 (NP_001163661.1). (**B**) Confocal images of larval brains stained with mouse anti-DNlg2^6D5^ (green) and rabbit anti-DVGLUT (red). Genotypes were WT, *elav*-*Gal4* \> *UAS-dnlg2*, and *elav*-*Gal4* \> *UAS-dnlg2*^*R598C*^. Scale bar, 50 μm. Arrows point at synapse area and arrowheads point at soma site. (**C**) Quantification of relative DNlg2 protein amount on synapse of each genotype. (**D**) Quantification of relative DNlg2 protein amount in soma of each genotype. (**E**) Immunoblotting analysis of DNlg2 in third instar larval muscle cells with shorter (30 sec) and longer (3 min) exposure time. Genotypes were *da*-*Gal4* \> WT, *da*-*Gal4* \> *UAS-dnlg2*, and *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^. The rabbit anti-DNlg2^CTF^ antibodies were used. (**F**) Quantification of the 70 kDa DNlg2 proportion in total proteins. Error bar indicates SEM. \*\**P* \< 0.01, \**P* \< 0.05.](mjx015f04){#mjx015F4}

To study the effect of the R451C mutation on DNlg2, a site-directed *UAS-dnlg2*^*R598C*^ transgene, which has the same chromosome insertion site with *UAS-dnlg2*, was generated. We used *elav*-*Gal4* to drive the expression of *UAS-dnlg2* and *UAS-dnlg2*^*R598C*^ in the nervous system, and then performed immunostaining with anti-DNlg2 (6D5) and anti-DVGLUT (synaptic marker) ([@mjx015C6]). *elav*-*Gal4* \> *UAS-dnlg2*^*R598C*^ flies displayed an abnormal distribution with high levels of DNlg2 in soma and low levels at synaptic regions, compared with *elav*-*Gal4* \> *UAS-dnlg2* (synaptic: 100% ± 5.3% in *elav*-*Gal4* \> *UAS-dnlg2* vs. 52.8% ± 2.3% in *elav*-*Gal4* \> *UAS-dnlg2*^*R598C*^; soma: 100% ± 5.1% in *elav*-*Gal4* \> *UAS-dnlg2* vs. 190.2% ± 3.5% in *elav*-*Gal4* \> *UAS-dnlg2*^*R598C*^) (Figure [4](#mjx015F4){ref-type="fig"}B−D). These observations indicate that the R598C mutation prevents the delivery of DNlg2 from cell bodies to synapses.

Furthermore, immunoblotting results showed that both 130 kDa and 70 kDa bands could be detected when *UAS-dnlg2* and *UAS-dnlg2*^*R598C*^ were overexpressed by *da*-*Gal4* (Figure [4](#mjx015F4){ref-type="fig"}E). However, in *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^ flies, we observed a predominant 130 kDa band, and only upon longer exposure (3 min), a faint 70 kDa band was visible. Inversely, the 70 kDa band was predominant in *da*-*Gal4* \> *UAS-dnlg2* transgenic flies (Figure [4](#mjx015F4){ref-type="fig"}E). The proportion of the 70 kDa DNlg2 in total DNlg2 proteins was severely reduced in *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^ flies (80% ± 4.8% in *da*-*Gal4* \> *UAS-dnlg2* vs. 37% ± 10.0% in *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^) (Figure [4](#mjx015F4){ref-type="fig"}F). These results demonstrated that the R598C mutation dramatically precludes DNlg2 cleavage.

Non-cleavable mutations of DNlg2 block its synapse transport {#mjx015s2f}
------------------------------------------------------------

As R598C mutant DNlg2 exhibited severe defects in proteolytic cleavage and retention in neuron cell bodies, we hypothesized that proteolytic cleavage may be required for the trafficking of DNlg2. Our biochemical data that the 130 kDa DNlg2 proteins are co-fractionated with the ER protein BiP support this idea. To further confirm this hypothesis *in vivo*, we generated *UAS-dnlg2*^*SF*^ (SF is the alanine substitutional mutation illustrated in Figure [3](#mjx015F3){ref-type="fig"}D) and *UAS-dnlg2*^*CTF*^ (deletion of the Q37−Y684 region) transgenes in the same chromosome insertion site with *UAS-dnlg2* and *UAS-dnlg2*^*R598C*^ (Figure [5](#mjx015F5){ref-type="fig"}A). Immunoblotting analysis showed the presence of only the 130 kDa DNlg2 in *da*-*Gal4* \> *UAS-DNlg2*^*SF*^ (Figure [5](#mjx015F5){ref-type="fig"}B). The *da*-*Gal4* \> *UAS*-*dnlg2*^*CTF*^ transgene successfully expressed a DNlg2 fragment lacking partial N-terminal sequence to mimic a cleaved DNlg2 with an obvious 70 kDa band (Figure [5](#mjx015F5){ref-type="fig"}B).

![CTF but not non-cleavable mutant DNlg2 is transported to dendrites or cell surfaces. (**A**) Schematic representation of mutant or N-terminal deleted DNlg2. (**B**) Immunoblotting analysis of *dnlg2* mutant, WT, and *UAS-dnlg2*, *UAS-dnlg2*^*R598C*^, *UAS-dnlg2*^*SF*^, *UAS-dnlg2*^*CTF*^ flies with *da*-*Gal4*. Third instar larval muscle cells were used. The rabbit anti-DNlg2^CTF^ antibodies were used. (**C**) Confocal images showing DNlg2 distributions in *pdf*-*Gal4* \> WT, *pdf*-*Gal4* \> *UAS-dnlg2*, *pdf*-*Gal4* \> *UAS-dnlg2*^*R598C*^, *pdf*-*Gal4* \> *UAS-dnlg2*^*SF*^, and *pdf*-*Gal4* \> *UAS-dnlg2*^*CTF*^ adult brain dendrite region, labeled with mouse anti-DNlg2^6D5^ (red) and rabbit anti-GFP (green). Scale bar, 10 μm. (**D**) Confocal images showing DNlg2 distributions of *da*-*Gal4* \> WT, *da*-*Gal4* \> *UAS-dnlg2*, *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^, *da*-*Gal4* \> *UAS-dnlg2*^*SF*^, and *da*-*Gal4* \> *UAS-dnlg2*^*CTF*^ epithelial cells, labeled with rabbit anti-DNlg2^CTF^ (green) and mouse anti-DLG (red). Scale bar, 25 μm.](mjx015f05){#mjx015F5}

To obtain the precise and clear localization of DNlg2, we took advantage of PDF neurons, which have large and abundant dendritic regions in adult fly brains ([@mjx015C19]). *UAS-dnlg2*, *UAS-dnlg2*^*R598C*^, *UAS-dnlg2*^*SF*^, and *UAS-dnlg2*^*CTF*^ were overexpressed in PDF neurons under the control of *pdf*-*Gal4*, with *UAS-mCD8::GFP* co-expressed to mark the PDF neuron. Immunostaining revealed that DNlg2^SF^, which only exhibits a 130 kDa band, was unable to be delivered to dendritic sites (Figure [5](#mjx015F5){ref-type="fig"}C). Of particular note is the appropriate translocation of *UAS-dnlg2*^*CTF*^ product, which highly suggested the necessity of proteolytic processing for DNlg2 trafficking (Figure [5](#mjx015F5){ref-type="fig"}C). Consistent with our observation that a small portion of DNlg2^R598C^ was cleaved, we also observed a weak signal of this mutant in dendritic regions, compared with normal DNlg2 (Figure [5](#mjx015F5){ref-type="fig"}C).

We also investigated whether mutant DNlg2 could be delivered to plasma membrane in non-neuronal cells. Third instar larval epithelial cells were dissected and stained with anti-DNlg2 (CTF, green) and anti-DLG (red). Immunostaining results showed that overexpressed DNlg2 and DNlg2^CTF^ could be delivered to cell surface and co-localized with DLG signaling (Figure [5](#mjx015F5){ref-type="fig"}D). However, R598C and SF mutant DNlg2 were accumulated intracellularly (Figure [5](#mjx015F5){ref-type="fig"}D). Together, these observations indicate that non-cleavable DNlg2 is restricted intracellularly and thus cannot be delivered to cell surface or synapse site.

BiP interacts with full-length but not cleaved DNlg2 and mediates the ER retention of full-length DNlg2 {#mjx015s2g}
-------------------------------------------------------------------------------------------------------

To illuminate the localization of non-cleavable DNlg2, we next performed double immunostaining experiments. We observed that non-cleavable DNlg2^R598C^ and DNlg2^SF^ were co-localized with the ER marker BiP ([@mjx015C11]), suggesting that the 130 kDa DNlg2 proteins were restricted in the ER (Figure [6](#mjx015F6){ref-type="fig"}A). We also observed increased expression levels of BiP in samples overexpressing *da*-*Gal4* \> *UAS-DNlg2*^*SF*^ and *da*-*Gal4* \> *UAS-DNlg2*^*R598C*^ (Figure [6](#mjx015F6){ref-type="fig"}A). BiP is an essential hsp70 resident protein in the ER, involved in polypeptide translocation, protein folding, and presumably protein degradation ([@mjx015C11]). To determine the role of BiP in DNlg2 cleavage, we compared the protein levels of BiP among different flies. Immunoblotting analysis showed that BiP levels were increased in *da*-*Gal4* \> *UAS-dnlg2* (192% ± 43.9%), *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^ (251% ± 48.3%), and *da*-*Gal4* \> *UAS-dnlg2*^*SF*^ (247% ± 40.7%) samples (Figure [6](#mjx015F6){ref-type="fig"}B and C). We did not observe any changes of BiP levels in *dnlg2*^*KO70*^ mutant (131% ± 12%), WT (100% ± 13.8%), and *da*-*Gal4* \> *UAS-dnlg2*^*CTF*^-overexpressing (127% ± 44.2%) flies (Figure [6](#mjx015F6){ref-type="fig"}B and C). These results suggested that only accumulation of full-length DNlg2 can increase BiP expression levels. In addition, co-immunoprecipitation experiments confirmed an *in vivo* interaction between BiP and the 130 kDa DNlg2 rather than 70 kDa DNlg2^CTF^ fragment (Figure [6](#mjx015F6){ref-type="fig"}D), demonstrating that BiP associates with the 130 kDa DNlg2 rather than the 70 kDa DNlg2.

![Full-length DNlg2 is retained in the ER through binding to BiP. (**A**) Confocal images showing non-cleavable DNlg2 (*da*-*Gal4* \> *UAS-dnlg2* and *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^) co-localized with BiP. Dissected epithelial cells were co-stained with rabbit anti-DNlg2^CTF^ (green) and rat anti-BiP (red, showing the ER). Scale bar, 25 μm. (**B**) Immunoblotting analysis of *dnlg2* mutant, WT, and *da*-*Gal4* \> *UAS-dnlg2*, *da*-*Gal4* \> *UAS-dnlg2*^*R598C*^, *da*-*Gal4* \> *UAS-dnlg2*^*SF*^, *da*-*Gal4* \> *UAS-dnlg2*^*CTF*^ flies with anti-BiP. (**C**) Quantification of relative BiP expression level in each genotype. (**D**) Co-immunoprecipitation of DNlg2 and BiP *in vivo*. (**E**) Immunoblotting analysis of da-*Gal4* overexpressing *UAS-dnlg2* and *UAS-dnlg2*^*SF*^ at WT or BiP RNAi background with rabbit anti-DNlg2^CTF^. (**F**) Immunoblotting analysis of *da-Gal4* \> *UAS-dnlg2*^*SF*^ and *da-Gal4* \> *UAS-BiP-RNAi,UAS-dnlg2*^*SF*^ with rabbit anti-DNlg2^CTF^. Samples were purified with plasma−membrane extraction kit. (**G**) Confocal images of *UAS-dnlg2*^*SF*^-overexpressing flies under BiP knockdown background with *da-Gal4*. Dissected epithelial cells were co-stained with rabbit anti-DNlg2^CTF^ (green) and mouse anti-DLG antibody (red). Scale bar, 20 μm.](mjx015f06){#mjx015F6}

We, therefore, speculated that such association may be responsible for the ER retention of the 130 kDa DNlg2. To confirm this hypothesis, we analyzed the effects of BiP knockdown on DNlg2 proteins by using *da-Gal4 \> UAS-BiP-RNAi* flies, where BiP expression level was decreased ([Supplementary Figure S3A and B](#sup1){ref-type="supplementary-material"}). The expression level of the 70 kDa DNlg2 was decreased, while the 130 kDa DNlg2 was increased in *da-Gal4 \> UAS-dnlg2, UAS-BiP-RNAi* flies (Figure [6](#mjx015F6){ref-type="fig"}E). The expression level of DNlg2^SF^ proteins was also increased in *da-Gal4 \> UAS-dnlg2*^*SF*^, *UAS-BiP-RNAi* flies (Figure [6](#mjx015F6){ref-type="fig"}E). These results indicate that BiP is involved in the maturation and degradation of the 130 kDa DNlg2.

Furthermore, we purified the plasma membrane proteins from *da-Gal4 \> UAS-dnlg2*^*SF*^ or *da-Gal4 \> UAS-dnlg2*^*SF*^, *UAS-BiP-RNAi* flies. Immunoblotting results showed that in *da-Gal4 \> UAS-dnlg2*^*SF*^ flies, DNlg2^SF^ proteins could not be detected in purified plasma membrane fractions (Figure [6](#mjx015F6){ref-type="fig"}F). Intriguingly, a small portion of DNlg2^SF^ proteins appeared in purified plasma membrane fractions from BiP RNAi flies (Figure [6](#mjx015F6){ref-type="fig"}F). Here, we used Fmr1 and α-Tubulin as negative controls, which could not be detected in plasma membrane fractions (Figure [6](#mjx015F6){ref-type="fig"}F). Similarly, a small portion of the 130 kDa DNlg2 could be detected in plasma membrane fractions from *da-Gal4 \> UAS-dnlg2, UAS-BiP-RNAi* flies ([Supplementary Figure S3C and D](#sup1){ref-type="supplementary-material"}). In addition, the third instar larval epithelial cells of *da-Gal4 \> UAS-dnlg2*^*SF*^, *UAS-BiP-RNAi* flies were dissected and stained with anti-DNlg2 (6D5, green) and anti-DLG (red). Immunostaning results showed that the 130 kDa DNlg2^SF^ proteins co-localized with DLG at epithelial cell surface in *da-Gal4 \> UAS-dnlg2*^*SF*^, *UAS-BiP-RNAi* flies (Figure [6](#mjx015F6){ref-type="fig"}G), indicating that the 130 kDa DNlg2 proteins might escape to the cell surface when the amount of BiP proteins are insufficient. Taken together, we demonstrated that BiP mediates full-length DNlg2 protein maturation and rigorously restricts full-length DNlg2 proteins in the ER, which plays vital roles in the maturation and cleavage of DNlg2.

DNlg2 CTF can rescue defective neuromuscular junction growth in dnlg2 mutant flies {#mjx015s2h}
----------------------------------------------------------------------------------

As the 130 kDa DNlg2 is restricted in the ER, it is easy to speculate that the 70 kDa DNlg2 is the functional isoform. It has been previously reported that DNlg2 is required for synapse development and function at the neuromuscular junction (NMJ). In the rescue experiments, our observations were consistent with previous data showing that the total number of boutons were significantly reduced in the *dnlg2* mutants compared with WT controls (100% ± 3.1% in WT vs. 62.9% ± 10.7% in *dnlg2*^*KO70*^) (Figure [7](#mjx015F7){ref-type="fig"}A and B). These changes could be rescued with ubiquitous expression of *UAS-dnlg2* (107% ± 5.0%) or *UAS-dnlg2*^*CTF*^ (101.7% ± 3.7%) driven by *da-Gal4* (Figure [7](#mjx015F7){ref-type="fig"}A and B). However, ubiquitous expression of *UAS-dnlg2*^*R598C*^ (65.8% ± 3.9%) or *UAS-dnlg2*^*SF*^ (54.4% ± 4.7%) driven by *da-Gal4* could not rescue the reduced bouton numbers (Figure [7](#mjx015F7){ref-type="fig"}A and B). These results suggest that the 70 kDa but not 130 kDa DNlg2 is functional.

![The 70 kDa DNlg2 promotes NMJ development. (**A**) Confocal images of NMJ6/7 from abdominal segment 2 of third instar larvae labeled with rabbit anti-HRP (green) and mouse anti-DLG (red), showing bouton phenotypes in WT, *dnlg2*^*KO70*^, and rescue lines with *UAS-dnlg2*, *UAS-dnlg2*^*R598C*^, *UAS-dnlg2*^*SF*^, *UAS-dnlg2*^*CTF*^ derived by *da*-*Gal4*. Scale bar, 25 μm. (**B**) Quantification of total bouton number at NMJ6/7, adjusted to WT bouton number. (**C**) Confocal images of synaptic boutons at NMJ4 labeled with rabbit anti-GluRIIB (green) and mouse anti-BRP (red), showing GluRIIB signal phenotypes in WT, *dnlg2*^*KO70*^, and rescue lines with *UAS-dnlg2*, *UAS-dnlg2*^*R598C*^, *UAS-dnlg2*^*SF*^, *UAS-dnlg2*^*CTF*^ derived by *da*-*Gal4*. Scale bar, 5 μm. (**D**) Quantification of GluRIIB signal intensity with 3D reconstructed confocal images.](mjx015f07){#mjx015F7}

In addition, we found that the postsynaptic GluRIIB signal was markedly reduced in *dnlg2* mutants compared with WT controls, which could also be restored through ubiquitous expression of *UAS-dnlg2* (113.4% ± 12.6%) or *UAS-dnlg2*^*CTF*^ (102.1% ± 10.2%) (Figure [7](#mjx015F7){ref-type="fig"}C and D). In contrast, *UAS-dnlg2*^*SF*^ (61.5% ± 12.6%) was unable to restore defective GluRIIB phenotypes, suggesting that non-cleavable DNlg2 is non-functional (Figure [7](#mjx015F7){ref-type="fig"}C and D). Intriguingly, *UAS-dnlg2*^*R598C*^ (98.4% ± 6.0%) rescued the defects in GluRIIB levels (Figure [7](#mjx015F7){ref-type="fig"}C and D). This might be arising from the small portion of cleaved 70 kDa DNlg2 in *UAS-dnlg2*^*R598C*^ flies.

Moreove, electrophysiology experiments with the rescue lines at the NMJ showed that non-cleavable DNlg2 could not rescue the reduced synaptic transmission in *dnlg2* mutants ([Supplementary Figure S4A−D](#sup1){ref-type="supplementary-material"}). Overall, these findings indicate that the 70 kDa DNlg2 proteins derived from the proteolytic cleavage reaction promote *Drosophila* NMJ development.

Discussion {#mjx015s3}
==========

It is well known that proteolytic cleavage plays critical roles in numerous biological processes such as development, differentiation, and cell migration. The cleavages of synapse adhesive molecules usually occur on the synapse in neuronal activity-dependent manner ([@mjx015C5]). Mouse Nlg1 proteolytic processing belongs to this type of neuronal activity-dependent event ([@mjx015C23]). The potential proteolytic cleavages were observed in DNlg2 ([@mjx015C30]) and DNlg3 ([@mjx015C37]) too. However, their mechanisms and functions had yet to be investigated.

In this study, we have revealed a quite different proteolytic processing event and provided compelling support for a novel hypothesis where, in contrast to the activity-dependent cleavage of Nlg1 on the synapse in rodents, the cleavage of DNlg2 is achieved in the ER and the cleaved 70 kDa DNlg2 is the functional isoform. In other words, the emerging model we present in this work suggests that the cleavage of DNlg2 in the ER is a requirement for its trafficking and function. Importantly, given that overexpression of autism-associated R598C mutation precludes the cleavage of DNgl2, which may be one of the potential autism pathogenesis, our study provides the first link among autism-associated mutation, proteolytic cleavage, and the trafficking of Nlgs. Thus, these findings provide a new insight in understanding the complicated regulatory mechanisms of Nlg maturation and trafficking in synapse development and function.

Nlgs were identified in different species from *C. elegans* to Human, including four homologs in mammals, plus an additional homolog on the Y chromosome in humans, and four homologs in *Drosophila* ([@mjx015C17]). However, due to diversifying independently during evolution, the name orders of DNlg1−4 are not in correspondence to mammal Nlg1−4, respectively ([@mjx015C17]).

Here, we found that the cleavage of DNlg2 is a novel mechanism underlying Nlg maturation and function, which is quite different from mammal Nlg1 cleavage. First, the cleavage of DNlg2 is continuous and ubiquitous but not activity dependent, suggesting that the cleavage modification plays critical roles in DNlg2 maturation. Second, the cleavage event is achieved in the ER but not on the cell surface, and is required for DNlg2 ER export. The finding that the endogenous full-length DNlg2 is only detected in the ER fractions strongly supports these conclusions. Finally, the cleavage efficiency of DNlg2 is extremely high. In WT mice, both full-length and cleaved CTF of Nlg1 proteins can be easily detected, and the expression levels of the two bands are similar ([@mjx015C31]). Such phenomenon is also observed for DNlg3 in WT flies ([@mjx015C37]). However, most of the full-length DNlg2 proteins were cleaved into 70 kDa. The different proteolytic cleavage mechanisms of DNlg2 and mammal Nlg1 suggest a variety of potential regulation manners for Nlg cleavage. As Nlgs are highly conserved, it would be interesting to determine in the future whether the DNlg2 cleavage mechanisms also exist in one of the undetermined mammal Nlgs.

Analyses on density gradient separation fractions demonstrate that the 130 kDa DNlg2 only exits in ER, while the 70 kDa DNlg2 exits in both ER and Golgi. By characterizing a variety of mutant transgenic flies, we also demonstrate that non-cleavable DNlg2 is restricted in the ER and is non-functional. The 130 kDa DNlg2 seems to be precursor immature proteins, for it is more sensitive to limited trypsin digestion. These results support the idea that the 130 kDa DNlg2 is restricted in the ER and cannot be delivered to the Golgi, and the proteolytic cleavage activates DNlg2.

Newly translated membrane proteins enter the ER in an unfolded state ([@mjx015C25]), whereby chaperones and enzymes regulate their folding and maturation ([@mjx015C26]). Here, the ER chaperone BiP can selectively interact with the 130 kDa DNlg2, rather than the 70 kDa DNlg2, for the maturation control of DNlg2. When BiP is knocked down, the ER restricted 130 kDa DNlg2 proteins can escape to the cell surface. Genetic analysis showed that these escaped 130 kDa DNlg2^SF^ might be still non-functional ([Supplementary Figure S5A and B](#sup1){ref-type="supplementary-material"}). The 130 kDa DNlg2 proteins associate with BiP until they turn into 70 kDa; otherwise, they will be degraded with the help of BiP. Our findings are consistent with previous data showing altered interactions of the mutant Nlgs with chaperones in the ER and arrest of transport along the secretory pathway with diversion to the proteasome ([@mjx015C7]). This may explain why the total expression levels of DNlg2^R598C^ or DNlg2^SF^ are much less than WT DNlg2 when they are overexpressed both *in vivo* and *in vitro*. These results indicate that BiP-involving cleavage may play important roles in the quality and quantity control of DNlg2. The expression levels of Nlgs are thought to be related with their physiological and pathological functions, which regulate the number and ratio of NMDA/AMPA receptors of the synapses ([@mjx015C3]). This may be the physiological reason why the 130 kDa DNlg2 has to be cleaved in the ER.

Usually, the level of the 130 kDa DNlg2 is quite low, while the level of the 70 kDa DNlg2 is very high. According to our findings, this is because the 130 kDa DNlg2 proteins are immature proteins and are cleaved into the 70 kDa isoform in the ER continuously. Therefore, we speculated that the 70 kDa DNlg2 proteins are functional. The rescue experiments showing that the 70 kDa DNlg2 can restore bouton development and GluRIIB defects support our hypothesis. This is also consistent with previous data showing that overexpression of Nlg1-CTF that lacks the extracellular domain retained the capacity to induce dendritic spines in granule cells ([@mjx015C31]), and that cytoplasmic domain of Nlg1 is necessary and sufficient for the induction of dendritic spines in transfected neurons ([@mjx015C18]). On the other hand, overexpressed 70 kDa DNlg2 may promote postsynaptic overgrowth, and thus compensate for the function of DNlg2-NTF. It is intriguing to determine whether the NTF contributes to synapse function or other neurological significances in the future.

Multiple independent mutations in Nlgs were identified in patients with autism, and most of the mutations localize to the α/β hydrolase fold domain of Nlgs, resulting in a loss of protein function. Of note is the R451C mutation in human NLG3 ([@mjx015C15]; [@mjx015C4]). This arginine is identical in all Nlgs, suggesting a critical role of this amino acid residue. Previous results show that these mutations in Nlgs impact their trafficking ([@mjx015C4]; [@mjx015C39]; [@mjx015C7]). However, it is remaining unknown whether these mutations affect the cleavage of Nlgs until now. Interestingly, the homology R598C mutation in DNlg2 affects the proteolytic cleavage and trafficking, leading to retention of DNlg2 in the ER. The similar trafficking defects observed in humans and *Drosophila* suggest that this autism-associated mutation has conserved effects, which might also affect NLG proteolytic cleavage in humans. Therefore, it is tempting to speculate that abnormities in the proteolytic processing of NLGs may be involved in the pathology of the neurodevelopmental diseases.

To the best of our knowledge, this study provides the first known link between the autism-associated mutation and proteolytic cleavage in Nlgs. People started to realize the cleavage modification to Nlgs from the year 2012, and only mouse/rat Nlg1 cleavage has been analyzed ([@mjx015C23]; [@mjx015C31]). Therefore, it is urgent to study the cleavage of mammal Nlg2, Nlg3, or Nlg4 and determine the cleavage of Nlgs in autism patients in the future.

It is interesting that the R598 is beyond the cleavage region Y642−T698 but its mutation still affects DNlg2 cleavage. Our mutational analyses indicate that a large region is required in DNlg2 cleavage reaction, and the proper structure and conformation, but not several amino acids, are crucial for the cleavage. Therefore, the R598C mutation may break the conformation instead of directly affecting cleavage site.

Finally, identification of responsible protease(s) and relevant auxiliary components in the ER would provide important information on the proteolytic control of Nlgs. It would be interesting to identify the protease(s) involved in DNlg2 cleavage in the future.

Materials and methods {#mjx015s4}
=====================

Fly stocks {#mjx015s4a}
----------

Flies were raised at 25°C (except those used in the *Gal4/Tub-Gal80*^*ts*^ experiments) with a 12-h light/dark cycle on standard medium. The WT fly strain used in this study was *w*^*1118*^. *elav*-*Gal4*, *C57*-*Gal4*, *pdf*-*Gal4*, *gmr*-*Gal4*, *repo*-*Gal4, da*-*Gal4*, and *attP* transgenic flies (35568) were obtained from the *Drosophila* Stock Center (Bloomington). BiP RNAi line (THU0848) was obtained from the Tsinghua Fly Center.

More detailed experimental procedures are described in [Supplementary material](#sup1){ref-type="supplementary-material"}.

Supplementary material {#mjx015s5}
======================

[Supplementary material is available at *Journal of Molecular Cell Biology* online](#sup1){ref-type="supplementary-material"}.
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